Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Berezov

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2008
BIBW-2992, a dual receptor tyrosine kinase inhibitor for the treatment of solid tumorsNatalie Minkovsky, Alan Berezov
Molecular Systems Biology|October 4, 2006
Towards comprehensive characterization of HER2 overexpressionAlan Berezov, Mark I Greene
Methods (San Diego, Calif.)|June 24, 2008
Modulation of biomolecular interactions with complex-binding small moleculesZheng Cai, Mark I Greene, Alan Berezov
Immunologic Research|July 15, 2003
Structure-based approaches to inhibition of erbB receptors with peptide mimeticsAlan Berezov, Mark I Greene, Ramachandran Murali
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
Targeted antireceptor therapy with monoclonal antibodies leads to the formation of inactivated tetrameric forms of ErbB receptorsKeiji Furuuchi, Alan Berezov, Toru Kumagai, et al.
The Protein Journal|December 6, 2005
Electron paramagnetic resonance and fluorescence studies of the conformation of aspartate aminotransferase bound to GroELAlan Berezov, Megan J McNeill, Ana Iriarte, et al.
International Immunopharmacology|June 23, 2009
Structural aspects of the FOXP3 regulatory complex as an immunopharmacological targetZhaocai Zhou, Xiaomin Song, Alan Berezov, et al.
Oncogene|February 13, 2002
HER2/Neu: mechanisms of dimerization/oligomerizationPatrick J Brennan, Toru Kumagai, Alan Berezov, et al.
DNA and Cell Biology|June 9, 2005
HER2-mediated internalization of a targeted prodrug cytotoxic conjugate is dependent on the valency of the targeting ligandVeronique Guillemard, Hinyu N Nedev, Alan Berezov, et al.
The Journal of Biological Chemistry|May 16, 2002
Disabling receptor ensembles with rationally designed interface peptidomimeticsAlan Berezov, Jinqiu Chen, Qingdu Liu, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2008
BIBW-2992, a dual receptor tyrosine kinase inhibitor for the treatment of solid tumorsNatalie Minkovsky, Alan Berezov
Molecular Systems Biology|October 4, 2006
Towards comprehensive characterization of HER2 overexpressionAlan Berezov, Mark I Greene
Methods (San Diego, Calif.)|June 24, 2008
Modulation of biomolecular interactions with complex-binding small moleculesZheng Cai, Mark I Greene, Alan Berezov
Immunologic Research|July 15, 2003
Structure-based approaches to inhibition of erbB receptors with peptide mimeticsAlan Berezov, Mark I Greene, Ramachandran Murali
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
Targeted antireceptor therapy with monoclonal antibodies leads to the formation of inactivated tetrameric forms of ErbB receptorsKeiji Furuuchi, Alan Berezov, Toru Kumagai, et al.
The Protein Journal|December 6, 2005
Electron paramagnetic resonance and fluorescence studies of the conformation of aspartate aminotransferase bound to GroELAlan Berezov, Megan J McNeill, Ana Iriarte, et al.
International Immunopharmacology|June 23, 2009
Structural aspects of the FOXP3 regulatory complex as an immunopharmacological targetZhaocai Zhou, Xiaomin Song, Alan Berezov, et al.
Oncogene|February 13, 2002
HER2/Neu: mechanisms of dimerization/oligomerizationPatrick J Brennan, Toru Kumagai, Alan Berezov, et al.
DNA and Cell Biology|June 9, 2005
HER2-mediated internalization of a targeted prodrug cytotoxic conjugate is dependent on the valency of the targeting ligandVeronique Guillemard, Hinyu N Nedev, Alan Berezov, et al.
The Journal of Biological Chemistry|May 16, 2002
Disabling receptor ensembles with rationally designed interface peptidomimeticsAlan Berezov, Jinqiu Chen, Qingdu Liu, et al.
Pageof 3